Abstract
Background In Australia, daily smoking prevalence has fallen below 10% as of 2022–2023. However, prevalence of recent illicit tobacco use has increased, from 1.6% in 2019 to 3.8% in 2025. Recent policy changes have restricted e-cigarette sales to pharmacies, yet illicit supply remains widespread. We aimed to estimate how increasing enforcement against illicit tobacco and e-cigarettes might affect future smoking, vaping and mortality. Methods We used the SHINE-Tobacco simulation model that combines a Markov model of yearly smoking, vaping and dual use transitions, with a proportional multistate lifetable of tobacco-related diseases. We compare a ‘business-as-usual’ (BAU) scenario in which overall smoking declines (based on 2001–2022/2023 trends), but illicitly traded tobacco and e-cigarettes remain widespread, to four hypothetical enforcement scenarios starting in 2025 that vary by intensity (maximum 90% reduction) and whether increased pharmacy e-cigarette use occurs. Findings Under BAU, daily smoking prevalence declined from 9.1% in 2024 to 6.1% in 2044, while vaping increased from 4.8% to 9.9%. High illicit market enforcement reduced smoking to 4.5% and vaping to 1.3% by 2044. The largest reduction in smoking occurred under high illicit enforcement alongside ongoing e-cigarette use (via pharmacies) for smoking cessation, reducing smoking to 3.0% and averting 8370 deaths over 20 years (95% uncertainty interval 6970–10 100). While the model was moderately sensitive to changes in BAU assumptions, enforcement scenario rankings remained the same across sensitivity analyses. Conclusions Future smoking trajectories in Australia are likely to depend on both illicit product availability and the role of e-cigarettes in cessation. Future research is required to determine how hypothetical enforcement impacts could be achieved.
Funding Information
  • National Health and Medical Research Council (GNT1198301)
  • National Health and Medical Research Council (GNT2026992)

This publication has 26 references indexed in Scilit: